Kengreal 50 MG vials
Ended Awarded
- Contract number
- SPE2DB26FX4LH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,540
Award facts
- Contract value 100% obligated
- $12,540.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,540.07 delivery order to AmerisourceBergen Drug Corp for KENGREAL 50 mg vials, a pharmaceutical product supporting federal medical procurement needs. This non-set-aside, firm fixed-price delivery order was executed on November 6, 2025, with an ultimate completion date of November 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is registered in the System for Award Management and serves as a critical vendor for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contractor's demonstrated capability to fulfill federal medical supply requirements through open competition, combined with its extensive pharmaceutical portfolio across multiple therapeutic domains, positions it to serve critical medical needs through this flexible contract vehicle.
Quick answers
Who was awarded contract SPE2DB26FX4LH?
SPE2DB26FX4LH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FX4LH worth?
The government has obligated $12,540 on SPE2DB26FX4LH.
Is contract SPE2DB26FX4LH an order under another contract?
Yes. SPE2DB26FX4LH is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX4LH competed?
The extent of competition for SPE2DB26FX4LH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award